Showing results (601-610 of 658) with videos related to
Sort By:
Pageof 66
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2012
Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03Eudocia Q Lee, Vinay K Puduvalli, Joel M Reid, et al.Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.Neuro-Oncology Advances|March 23, 2026
Discovery of genetic susceptibility variants in pediatric and adult ependymomaJoshua D Strauss, Priya B Shetty, Spiridon Tsavachidis, et al.Neuro-Oncology Advances|April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trialByram H Ozer, Adam L Cohen, Howard Colman, et al.Neuro-Oncology|November 23, 2019
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophagesJohn de Groot, Marta Penas-Prado, Kristin Alfaro-Munoz, et al.Nature Communications|March 10, 2026
Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastomaJongHoon Ha, Yifan Wang, Yifan Ma, et al.Cancer Cell|August 13, 2024
Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPDMayra Shanley, May Daher, Jinzhuang Dou, et al.Journal of Neuro-Oncology|March 8, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trialAmanda L King, Kayla N Roche, Heather E Leeper, et al.Eclinicalmedicine|November 17, 2022
Relationship between RANO-PRO Working Group standardised priority constructs and disease progression among malignant glioma patients: A retrospective cohort studyElizabeth Vera, Alexa Christ, Ewa Grajkowska, et al.Genes & Development|April 8, 2024
Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotypeNicholas Nuechterlein, Allison Shelbourn, Frank Szulzewsky, et al.Pageof 66